Table 2.
Risk factors of mortality in severe acute respiratory syndrome (SARS) by univariate analysis
Relative risk (99% CI) | P value | |
---|---|---|
Use of inotropes | 15.77 (7.539–32.99) | <0.001 |
Acute renal impairment | 16.91 (8.368–34.16) | <0.001 |
Acute respiratory distress syndrome | 10.28 (4.854–21.77) | <0.001 |
Systolic blood pressure | 1.014 (0.997–1.031) | 0.032 |
White blood cells | 1.066 (0.988–1.150) | 0.029 |
Lymphocyte count | 0.529 (0.209–1.339) | 0.077 |
Nadir white blood cells | 1.160 (1.057–1.272) | <0.001 |
Nadir lymphocyte count | 0.016 (0.001–0.217) | <0.001 |
Plasma albumin on admission | 0.890 (0.841–0.942) | <0.001 |
Peak plasma creatine phosphokinase > 1500a | 6.689 (1.699–26.34) | <0.001 |
Plasma alanine aminotransferase on admission | 1.005 (1.001–1.009) | 0.004 |
Age | 1.049 (1.029–1.068) | <0.001 |
Patients with creatine phosphokinase less than 1500 serve as the reference group.